GORE® Viabahn® Endoprosthesis
GPTKB entity
Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:hospital
|
gptkbp:bfsLayer |
6
|
gptkbp:bfsParent |
gptkb:Gore_Endovascular
gptkb:Gore_Interventional_Devices |
gptkbp:availability |
widely available in hospitals
|
gptkbp:available_sizes |
various lengths available
|
gptkbp:clinical_trial |
endovascular procedures
multiple studies conducted treatment of stenosis various phases of trials conducted widely used in clinical practice |
gptkbp:coat_of_arms |
hydrophilic coating
|
gptkbp:competitors |
competes with other vascular devices
|
gptkbp:complications |
risk of thrombosis
not suitable for all vascular conditions potential risks discussed with patients |
gptkbp:contraindication |
not suitable for all patients
|
gptkbp:design |
stent graft
|
gptkbp:diameter |
various diameters available
|
gptkbp:education |
patients should be informed about risks
|
gptkbp:effective_date |
FDA approved
|
gptkbp:events |
long-term follow-up recommended
regular monitoring required |
gptkbp:features |
flexible design
|
gptkbp:feedback |
high satisfaction rates reported
positive reviews from clinicians |
gptkbp:first_introduced |
gptkb:1997
|
gptkbp:future_plans |
future studies planned to assess long-term effects
|
gptkbp:has_experience_in |
surgeon skill impacts success
|
https://www.w3.org/2000/01/rdf-schema#label |
GORE® Viabahn® Endoprosthesis
|
gptkbp:innovation |
continuous improvements made
|
gptkbp:invention |
patented technology
|
gptkbp:is_compared_to |
compared to other stent grafts
|
gptkbp:is_effective_against |
demonstrated efficacy in studies
|
gptkbp:is_monitored_by |
requires follow-up imaging
|
gptkbp:is_used_for |
vascular interventions
|
gptkbp:manufacturer |
gptkb:W._L._Gore_&_Associates
|
gptkbp:market |
monitored for long-term safety
|
gptkbp:marketed_as |
Viabahn® stent graft
|
gptkbp:material |
e PTFE
|
gptkbp:population |
adults with vascular issues
|
gptkbp:price |
varies by region and provider
|
gptkbp:provides_information_on |
recommended for specific conditions
included in vascular surgery guidelines |
gptkbp:recruitment |
careful selection improves outcomes
|
gptkbp:regulatory_compliance |
CE marked in Europe
|
gptkbp:research |
ongoing research into effectiveness
|
gptkbp:risk_factor |
age and comorbidities affect outcomes
|
gptkbp:safety_features |
generally safe when used correctly
|
gptkbp:shipping_options |
percutaneous
|
gptkbp:specialties |
specific techniques recommended for use
|
gptkbp:training |
training for proper use recommended
|
gptkbp:treatment |
gptkb:peripheral_artery_disease
improved blood flow generally favorable outcomes reported |